Clinical Epidemiological Workbench

Coffee & Tea Intake Health Risk Explorer

Model based on meta-analyses and reports on cardiometabolic health. Discover how daily cups of coffee or tea balance protective risk reductions against excessive caffeine thresholds.

Type 2 Diabetes
24 % lower
Peak relative risk reduction with chlorogenic acid and polyphenol bioactive exposure.
Coronary Heart Disease
18 % lower
Cardiovascular endothelium & antioxidant protective mechanism.
Stroke Risk
20 % lower
Reduced microvascular thrombosis and enhanced cerebral perfusion.

Cardiometabolic Dose-Response Curve

J-shaped non-linear relative risk reduction curve from 0 to 8 daily cups

Optimal Protective Zone
Diabetes Reduction (%)
Heart Disease Reduction (%)
Stroke Reduction (%)
Optimal Zone (3ā€“4 cups)
Excess Intake Warning (>5.5 cups)
Report: Optimal Protective Intake Observed
Consuming 3.5 cups of medium-brew coffee daily correlates with an estimated 24% reduction in Type 2 Diabetes risk, 18% reduction in Coronary Heart Disease risk, and 20% lower stroke risk. Estimated daily caffeine of 332 mg stays within the FDA and EFSA recommended safe ceiling (≤400 mg/day).
Clinical Context & Evidence Grounding: As reported by @NBCNews and published in large prospective cardiometabolic cohorts (including the UK Biobank and European Prospective Investigation into Cancer and Nutrition), moderate consumption of 3 to 4 caffeinated cups daily is associated with substantial cardiometabolic risk reduction. Doses >5 cups show diminishing returns or adverse cardiovascular jitter depending on caffeine clearance phenotypes.